✦ LIBER ✦

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

✍ Scribed by Siegel-Lakhai, W S; Crul, M; Zhang, S; Sparidans, R W; Pluim, D; Howes, A; Solanki, B; Beijnen, J H; Schellens, J H M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of the

✍ StevenJ. Cohen; James Gallo; NancyL. Lewis; R.Katherine Alpaugh; Louis Gentner; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 189 KB

A phase I safety, pharmacological, and b

✍ Laura Q. M. Chow; S. Gail Eckhardt; Cindy L. O’Bryant; Mary Kay Schultz; Mark Mo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 697 KB

Phase I study of the multidrug resistanc

✍ Lyly H. Lê; Malcolm J. Moore; Lillian L. Siu; Amit M. Oza; Martha MacLean; Bryn 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 285 KB

Phase I and pharmacological study of the

✍ Konings, I R H M; de Jonge, M J A; Burger, H; van der Gaast, A; van Beijsterveld 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

Phase IB study of sorafenib in combinati

✍ B. Schultheis; G. Kummer; M. Zeth; E. Brendel; C. Xia; M. Kornacker; D. Strumber 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 282 KB

A phase I and pharmacological study of t

✍ Wall, L; Talbot, D C; Bradbury, P; Jodrell, D I 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB